Novartis

Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction
Clinical Trials Arena
Mon, 09/16/24 - 10:56 am
Novartis
Kisqali
breast cancer
clinical trials
ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival
Fierce Pharma
Fri, 09/13/24 - 11:12 am
Merck
Welireg
renal cell carcinoma
Novartis
Afinitor
ESMO
clinical trials
Novartis ignites new stage of Voyager pact with $15M capsid deal
Fierce Biotech
Thu, 09/5/24 - 11:28 am
Novartis
Voyager Therapeutics
capsids
gene therapy
Novartis builds out radiopharma production with expansion, new factory
BioPharma Dive
Wed, 09/4/24 - 10:44 pm
Novartis
radiopharmaceuticals
Indianapolis
California
cancer
Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
protein degradation
Arvinas
Merck KGaA
Sanofi
Pfizer
Novartis
Novartis and Genentech’s Xolair is rising rapidly on TV
Medical Marketing and Media
Thu, 08/29/24 - 06:11 pm
Novartis
Genentech
Xolair
television ads
Novartis taps Lindy to turn biologic drugs into at-home injectables, puts nearly $1B on the line
Fierce Pharma
Wed, 08/28/24 - 11:46 am
Novartis
Lindy Biosciences
drug delivery
Novartis builds case for Leqvio with monotherapy data
Pharmaphorum
Wed, 08/28/24 - 11:29 am
Novartis
Leqvio
cholesterol
clinical trials
Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats
Investors Business Daily
Mon, 08/26/24 - 11:11 am
Galapagos
CAR-T
FDA
non-Hodgkin lymphoma
Gilead Sciences
Novartis
Novartis receives binding offer from Siemens Healthineers for molecular imaging business
Reuters
Sun, 08/25/24 - 11:02 pm
Novartis
M&A
Siemens Healthineers
molecular imaging
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Fierce Biotech
Thu, 08/22/24 - 11:18 am
Novartis
Chinook Therapeutics
kidney disease
venture capital
Versant Ventures
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Novartis loses initial bid to block generic of best-selling heart drug
Reuters
Mon, 08/12/24 - 05:57 pm
Novartis
legal
MSN Pharmaceuticals
Entresto
heart failure
generics
Novartis' Complement Inhibitor Fabhalta Approved for IgAN
Contract Pharma
Mon, 08/12/24 - 05:52 pm
FDA
Novartis
Fabhalta
primary IgA nephropathy
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Fri, 08/9/24 - 11:25 am
Sandoz
earnings
biosimilars
Humira
AbbVie
Novartis
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
FDA approves Novartis' kidney disease drug
Reuters
Wed, 08/7/24 - 11:02 pm
Novartis
FDA
Fabhalta
kidney disease
paroxysmal nocturnal hemoglobinuria
Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims
Reuters
Mon, 08/5/24 - 11:12 pm
Novartis
Viatris
R&D
legal
Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations
BioSpace
Mon, 08/5/24 - 11:21 am
Ribon Therapeutics
AbbVie
JNJ
Novartis
Pfizer
PARP inhibitors
Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal
Fierce Biotech
Wed, 07/24/24 - 11:09 pm
Novartis
Dren Bio
cancer
bispecifics

Pages